Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells

Masuko Ushio-Fukai, Kathy K. Griendling, Peter L. Becker, Lula Hilenski, Sean Halleran, R. Wayne Alexander

Research output: Contribution to journalArticle

256 Citations (Scopus)

Abstract

Angiotensin II (Ang II) is a vasoactive hormone with critical roles in vascular smooth muscle cell growth, an important feature of hypertension and atherosclerosis. Many of these effects are dependent on the production of reactive oxygen species (ROS). Ang II induces phosphorylation of the epidermal growth factor (EGF) receptor (EGF-R), which serves as a scaffold for various signaling molecules. Here, we provide novel evidence that ROS are critical mediators of EGF-R transactivation by Ang II. Pretreatment of vascular smooth muscle cells with the antioxidants diphenylene iodonium, Tiron, N-acetylcysteine, and ebselen significantly inhibited (≈80% to 90%) tyrosine phosphorylation of the EGF-R by Ang II but not by EGF. Of the 5 autophosphorylation sites on the EGF-R, Ang II mainly phosphorylated Tyr1068 and Tyr1173 in a redox-sensitive manner. The Src family kinase inhibitor PP1, overexpression of kinase-inactive c-Src, or chelation of intracellular Ca2+ attenuated EGF-R transactivation. Although antioxidants had no effects on the Ca2+ mobilization or phosphorylation of Ca2+-dependent tyrosine kinase Pyk2, they inhibited c-Src activation by Ang II, suggesting that c-Src is 1 signaling molecule that links ROS and EGF-R phosphorylation. Furthermore, Ang II-induced tyrosine phosphorylation of the autophosphorylation site and the SH2 domain of c-Src was redox sensitive. These findings emphasize the importance of ROS in specific Ang II-stimulated growth-related signaling pathways and suggest that redox-sensitive EGF-R transactivation may be a potential target for antioxidant therapy in vascular disease.

Original languageEnglish (US)
Pages (from-to)489-495
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume21
Issue number4
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Vascular Smooth Muscle
Epidermal Growth Factor Receptor
Angiotensin II
Transcriptional Activation
Smooth Muscle Myocytes
Epidermal Growth Factor
Reactive Oxygen Species
Phosphorylation
Oxidation-Reduction
Antioxidants
Tyrosine
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
src Homology Domains
src-Family Kinases
Acetylcysteine
Growth
Vascular Diseases
Protein-Tyrosine Kinases
Atherosclerosis
Hormones

Keywords

  • Angiotensin II
  • Epidermal growth factor receptors
  • Reactive oxygen species
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. / Ushio-Fukai, Masuko; Griendling, Kathy K.; Becker, Peter L.; Hilenski, Lula; Halleran, Sean; Alexander, R. Wayne.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 21, No. 4, 01.01.2001, p. 489-495.

Research output: Contribution to journalArticle

Ushio-Fukai, Masuko ; Griendling, Kathy K. ; Becker, Peter L. ; Hilenski, Lula ; Halleran, Sean ; Alexander, R. Wayne. / Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. In: Arteriosclerosis, thrombosis, and vascular biology. 2001 ; Vol. 21, No. 4. pp. 489-495.
@article{aecc344242c5412e868c0a4ec11925d5,
title = "Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells",
abstract = "Angiotensin II (Ang II) is a vasoactive hormone with critical roles in vascular smooth muscle cell growth, an important feature of hypertension and atherosclerosis. Many of these effects are dependent on the production of reactive oxygen species (ROS). Ang II induces phosphorylation of the epidermal growth factor (EGF) receptor (EGF-R), which serves as a scaffold for various signaling molecules. Here, we provide novel evidence that ROS are critical mediators of EGF-R transactivation by Ang II. Pretreatment of vascular smooth muscle cells with the antioxidants diphenylene iodonium, Tiron, N-acetylcysteine, and ebselen significantly inhibited (≈80{\%} to 90{\%}) tyrosine phosphorylation of the EGF-R by Ang II but not by EGF. Of the 5 autophosphorylation sites on the EGF-R, Ang II mainly phosphorylated Tyr1068 and Tyr1173 in a redox-sensitive manner. The Src family kinase inhibitor PP1, overexpression of kinase-inactive c-Src, or chelation of intracellular Ca2+ attenuated EGF-R transactivation. Although antioxidants had no effects on the Ca2+ mobilization or phosphorylation of Ca2+-dependent tyrosine kinase Pyk2, they inhibited c-Src activation by Ang II, suggesting that c-Src is 1 signaling molecule that links ROS and EGF-R phosphorylation. Furthermore, Ang II-induced tyrosine phosphorylation of the autophosphorylation site and the SH2 domain of c-Src was redox sensitive. These findings emphasize the importance of ROS in specific Ang II-stimulated growth-related signaling pathways and suggest that redox-sensitive EGF-R transactivation may be a potential target for antioxidant therapy in vascular disease.",
keywords = "Angiotensin II, Epidermal growth factor receptors, Reactive oxygen species, Vascular smooth muscle",
author = "Masuko Ushio-Fukai and Griendling, {Kathy K.} and Becker, {Peter L.} and Lula Hilenski and Sean Halleran and Alexander, {R. Wayne}",
year = "2001",
month = "1",
day = "1",
doi = "10.1161/01.ATV.21.4.489",
language = "English (US)",
volume = "21",
pages = "489--495",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells

AU - Ushio-Fukai, Masuko

AU - Griendling, Kathy K.

AU - Becker, Peter L.

AU - Hilenski, Lula

AU - Halleran, Sean

AU - Alexander, R. Wayne

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Angiotensin II (Ang II) is a vasoactive hormone with critical roles in vascular smooth muscle cell growth, an important feature of hypertension and atherosclerosis. Many of these effects are dependent on the production of reactive oxygen species (ROS). Ang II induces phosphorylation of the epidermal growth factor (EGF) receptor (EGF-R), which serves as a scaffold for various signaling molecules. Here, we provide novel evidence that ROS are critical mediators of EGF-R transactivation by Ang II. Pretreatment of vascular smooth muscle cells with the antioxidants diphenylene iodonium, Tiron, N-acetylcysteine, and ebselen significantly inhibited (≈80% to 90%) tyrosine phosphorylation of the EGF-R by Ang II but not by EGF. Of the 5 autophosphorylation sites on the EGF-R, Ang II mainly phosphorylated Tyr1068 and Tyr1173 in a redox-sensitive manner. The Src family kinase inhibitor PP1, overexpression of kinase-inactive c-Src, or chelation of intracellular Ca2+ attenuated EGF-R transactivation. Although antioxidants had no effects on the Ca2+ mobilization or phosphorylation of Ca2+-dependent tyrosine kinase Pyk2, they inhibited c-Src activation by Ang II, suggesting that c-Src is 1 signaling molecule that links ROS and EGF-R phosphorylation. Furthermore, Ang II-induced tyrosine phosphorylation of the autophosphorylation site and the SH2 domain of c-Src was redox sensitive. These findings emphasize the importance of ROS in specific Ang II-stimulated growth-related signaling pathways and suggest that redox-sensitive EGF-R transactivation may be a potential target for antioxidant therapy in vascular disease.

AB - Angiotensin II (Ang II) is a vasoactive hormone with critical roles in vascular smooth muscle cell growth, an important feature of hypertension and atherosclerosis. Many of these effects are dependent on the production of reactive oxygen species (ROS). Ang II induces phosphorylation of the epidermal growth factor (EGF) receptor (EGF-R), which serves as a scaffold for various signaling molecules. Here, we provide novel evidence that ROS are critical mediators of EGF-R transactivation by Ang II. Pretreatment of vascular smooth muscle cells with the antioxidants diphenylene iodonium, Tiron, N-acetylcysteine, and ebselen significantly inhibited (≈80% to 90%) tyrosine phosphorylation of the EGF-R by Ang II but not by EGF. Of the 5 autophosphorylation sites on the EGF-R, Ang II mainly phosphorylated Tyr1068 and Tyr1173 in a redox-sensitive manner. The Src family kinase inhibitor PP1, overexpression of kinase-inactive c-Src, or chelation of intracellular Ca2+ attenuated EGF-R transactivation. Although antioxidants had no effects on the Ca2+ mobilization or phosphorylation of Ca2+-dependent tyrosine kinase Pyk2, they inhibited c-Src activation by Ang II, suggesting that c-Src is 1 signaling molecule that links ROS and EGF-R phosphorylation. Furthermore, Ang II-induced tyrosine phosphorylation of the autophosphorylation site and the SH2 domain of c-Src was redox sensitive. These findings emphasize the importance of ROS in specific Ang II-stimulated growth-related signaling pathways and suggest that redox-sensitive EGF-R transactivation may be a potential target for antioxidant therapy in vascular disease.

KW - Angiotensin II

KW - Epidermal growth factor receptors

KW - Reactive oxygen species

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0035049226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035049226&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.21.4.489

DO - 10.1161/01.ATV.21.4.489

M3 - Article

C2 - 11304462

AN - SCOPUS:0035049226

VL - 21

SP - 489

EP - 495

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 4

ER -